Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NewGenIvf Group Limited Warrants (NIVFW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: NIVFW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -6.25% | Avg. Invested days 53 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.13 | 52 Weeks Range 0.01 - 0.06 | Updated Date 06/3/2025 |
52 Weeks Range 0.01 - 0.06 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.66% | Operating Margin (TTM) -85.51% |
Management Effectiveness
Return on Assets (TTM) -17.99% | Return on Equity (TTM) -53.76% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 112699 |
Shares Outstanding - | Shares Floating 112699 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
NewGenIvf Group Limited Warrants
Company Overview
History and Background
It is impossible to provide a specific and accurate history of NewGenIvf Group Limited Warrants, including its founding year, significant milestones, and evolution over time, as 'warrants' are derivative securities and not companies themselves. Warrants are issued by a company (in this case, likely NewGenIvf Group Limited) giving the holder the right to purchase shares of the company's stock at a specified price within a specific time period.
Core Business Areas
Leadership and Structure
Warrants do not have a leadership team or organizational structure. They are financial instruments.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
The market for warrants depends on the underlying stock (NewGenIvf Group Limited). The warrant's value is influenced by factors affecting the stock price, such as industry trends, company performance, and overall market conditions.
Positioning
The positioning of the warrant is entirely dependent on NewGenIvf Group Limited's position in its industry and the warrant's terms (exercise price and expiration date).
Total Addressable Market (TAM)
The TAM for the warrant is directly related to the market capitalization and trading volume of NewGenIvf Group Limited and the attractiveness of the warrant's terms.
Upturn SWOT Analysis
Strengths
- Potential for high leverage (gains if underlying stock price increases significantly)
- Lower initial cost compared to purchasing the underlying stock directly
Weaknesses
- Warrants expire and become worthless if not exercised
- Highly sensitive to changes in the underlying stock price
- Limited upside potential compared to owning the stock if the exercise price is too high
Opportunities
- Trading strategies based on anticipated stock price movements
- Potential for quick profits in a rising market
- Arbitrage opportunities between the warrant and the underlying stock
Threats
- Decline in the underlying stock price
- Expiration of the warrant without being exercised
- Changes in market sentiment or economic conditions
Competitors and Market Share
Key Competitors
Competitive Landscape
Warrants do not have direct competitors. Their value is relative to the underlying stock and other financial instruments related to it (e.g., options).
Growth Trajectory and Initiatives
Historical Growth: The historical growth of a warrant is directly tied to the historical performance of the underlying stock.
Future Projections: Future projections for warrant value are based on analysts' estimates for the underlying stock (NewGenIvf Group Limited).
Recent Initiatives: Not applicable to warrants, but could relate to NewGenIvf Group Limited.
Summary
Analyzing NewGenIvf Group Limited Warrants requires understanding the company's underlying stock. Warrant performance hinges on stock price fluctuations and warrant terms. They offer leveraged gains but also significant risks, including expiration without value. Success depends on accurate stock price prediction.
Peer Comparison
Sources and Disclaimers
Data Sources:
Disclaimers:
The analysis is based on publicly available information and general knowledge of warrants. It is not financial advice. Investing in warrants involves significant risk.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NewGenIvf Group Limited Warrants
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-04-04 | Co-Founder, Chairman & CEO Mr. Wing Fung Siu | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 76 | Website https://newgenivf.com |
Full time employees 76 | Website https://newgenivf.com | ||
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.